tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Balaji Prasad, 19 are a SELL (8.88%), 29 are a HOLD (13.55%), 166 are a BUY (77.57%).
Analyst Balaji Prasad, carries an average stock price target met ratio of 56.74% that have a potential upside of 27.01% achieved within 341 days. Previously, Balaji Prasad worked at BARCLAYS.
Balaji Prasad’s has documented 422 price targets and ratings displayed on 28 stocks. The coverage was on Healthcare, Energy sectors.
Most recent stock forecast was given on EOLS, Evolus at 05-Mar-2025.
Analyst best performing recommendations are on LGND (LIGAND PHARMACEUTICALS).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $123.52 was fulfilled within 1 day with a profit of $11.16 (9.93%) receiving and performance score of 99.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-Sep-2022
$9
$4.24 (89.08%)
$10
3 months 2 days ago
(27-Apr-2026)
13/26 (50%)
$3.42 (61.29%)
164
Hold Since 25-Feb-2026
$7
$2.24 (47.06%)
$8
5 months 4 days ago
(25-Feb-2026)
1/6 (16.67%)
$0.89 (14.57%)
190
Hold Since 25-Jul-2024
$8
$3.24 (68.07%)
$7
6 months 22 days ago
(07-Jan-2026)
1/2 (50%)
$0.1 (1.27%)
53
Hold Since 10-Jul-2024
$8
$3.24 (68.07%)
1 years 2 months 24 days ago
(05-May-2025)
2/2 (100%)
$3.07 (62.27%)
86
Hold Since 22-Jan-2021
$3
$-1.76 (-36.97%)
1 years 11 months 27 days ago
(02-Aug-2024)
11/13 (84.62%)
$-2.63 (-46.71%)
164
What Year was the first public recommendation made by Balaji Prasad?
